-
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)
-
Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
-
Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma
-
Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC)
-
Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics
-
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges
-
Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study
-
Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC
-
A Concise Review of the Approved MET TKIs (Savolitinib, Gumarontinib, Vebreltinib, Tepotinib, Capmatinib) in China for MET Exon 14 Splice Site Mutated (METex14+) NSCLC Circa 2025
-
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
-
How Should IgG Seroconversion to Aspergillus fumigatus be Interpreted in Children With Cystic Fibrosis
-
Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
-
The acute respiratory distress syndrome in 2013
-
Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD
-
Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
-
Bacteria in COPD; their potential role and treatment
-
MicroRNAs implicated in dysregulation of gene expression following human lung transplantation
-
Role of WWOX and NF-κB in lung cancer progression
-
The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update
-
Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
-
Acute lung injury and the role of histones
-
Secretion properties, clearance, and therapy in airway disease
-
Epidemiology of bronchial asthma and asthma control assessment in Henan Province, China
-
Diagnosis and management of interstitial lung disease
